Report cover image

Gene Editing Therapeutics Market

Publisher BCC Research
Published Aug 30, 2024
Length 111 Pages
SKU # WA19136266

Description

Gene Editing Therapeutics Market



Report Scope:

This report highlights the current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also surveys the competitive environment, including coverage of the pipeline activities adopted by market players, and it includes market projections for 2029. Also included are company profiles of key players, featuring detailed information regarding each company’s business segments, financials, product portfolios and recent developments.

Report Includes:

15 data tables and 42 additional tables

An analysis of the current and future global markets for gene editing therapeutics

Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue forecasts for the global gene editing therapeutics market, with market share analysis by region

Discussion of the market dynamics, opportunities, and challenges, as well as emerging technologies

Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes

Competitive intelligence, including companies’ market shares, recent M&A activity, and venture funding

Company profiles of major players within the industry, including CRISPR Therapeutics, Vertex Pharmaceuticals, and Intellia Therapeutics

Companies Mentioned

Allogene Therapeutics
Beam Therapeutics
Caribou Biosciences Inc.
Crispr Therapeutics
Editas Medicine
Intellia Therapeutics Inc.
Precision Biosciences
Sangamo Therapeutics
Vertex Pharmaceuticals Inc.
Verve Therapeutics Inc.
Vor Bio

Table of Contents

111 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Introduction
Genome-Editing Tool Types
Meganucleases
Zinc Finger Nucleases
Transcription Activator-like Effector Nucleases
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
Gene editing Therapeutics
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
Increasing Prevalence of Chronic Disease
Increasing Prevalence of Rare Genetic Disorders
Precision Medicine
Increasing Strategic Initiatives
Market Restraints
Stringent Regulatory Frameworks and Time-Consuming Approval Processes
High Cost of Treatment
Adverse Events and Long-Term Monitoring
Lack of Skilled Workforce
Off-Target Impact
Market Challenges
Patent Disputes
Governmental Policies and Regulations
Ethical Issues
Market Opportunities
Chapter 4 Emerging Technologies and Developments
Introduction
Base Editing
Prime Editing
Cas-Clover and Cas-FOKl
CRISPR Interference and CRISPR Activation
RNA Editing
Artificial Intelligence in Genome Editing
Chapter 5 Pipeline Analysis
Overview
Clinical Trial Analysis Based on Technology
Clinical Trial Analysis Based on Diseases
Designations for Pipeline Drugs
Chapter 6 Patent Analysis
Chapter 7 Market Analysis
Introduction
Casgevy
Market Overview
Market Analysis
Market by Region
North America
Europe
Emerging Markets
Chapter 8 Competitive Intelligence
Strategic Initiatives
Competitive Landscape
Chapter 9 Sustainability in the Gene Editing Therapeutics Market: Environmental, Social and Governance (ESG) Perspectives
Introduction
ESG Practices in the Gene Editing Companies
Concluding Remarks from BCC Research
Chapter 10 Appendix
Methodology
Sources
Acronyms
Company Profiles
ALLOGENE THERAPEUTICS
BEAM THERAPEUTICS
CARIBOU BIOSCIENCES INC.
CRISPR THERAPEUTICS
EDITAS MEDICINE
INTELLIA THERAPEUTICS INC.
PRECISION BIOSCIENCES
SANGAMO THERAPEUTICS
VERTEX PHARMACEUTICALS INC.
VERVE THERAPEUTICS INC.
VOR BIO

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us